Page last updated: 2024-08-24

2,5-dimethoxy-4-bromoamphetamine and spiperone

2,5-dimethoxy-4-bromoamphetamine has been researched along with spiperone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glennon, RA1
Mutel, V; Sleight, AJ; Stam, NJ; Vanderheyden, PM1
Egan, CT; Herrick-Davis, K; Teitler, M1
Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D1
Done, CJ; Sharp, T1
Barker, EL; Burris, KD; Sanders-Bush, E1

Reviews

1 review(s) available for 2,5-dimethoxy-4-bromoamphetamine and spiperone

ArticleYear
Central serotonin receptors as targets for drug research.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:1

    Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin

1987

Other Studies

5 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and spiperone

ArticleYear
Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
    Biochemical pharmacology, 1996, Jan-12, Volume: 51, Issue:1

    Topics: 3T3 Cells; Animals; Binding, Competitive; Cell Membrane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Humans; Ketanserin; Mice; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

1996
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1

    Topics: Animals; Antipsychotic Agents; COS Cells; Mutagenesis, Site-Directed; Phosphatidylinositols; Protein Conformation; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship

1998
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2004
Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
    British journal of pharmacology, 1992, Volume: 107, Issue:1

    Topics: Amphetamines; Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electrophysiology; Hippocampus; Male; Neurons; Norepinephrine; p-Chloroamphetamine; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin Receptor Agonists; Spiperone; Sulpiride

1992
Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexus.
    Brain research, 1991, Jun-28, Volume: 552, Issue:2

    Topics: Animals; Cells, Cultured; Choroid Plexus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Fibroblasts; Haloperidol; Hydrolysis; Inositol Phosphates; Ketanserin; Lysergic Acid Diethylamide; Male; Mianserin; Phosphatidylinositols; Prazosin; Rabbits; Receptors, Serotonin; Serotonin; Spiperone

1991